The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 08, 2022

Filed:

Dec. 21, 2018
Applicant:

Ontario Institute for Cancer Research (Oicr), Toronto, CA;

Inventors:

Rima Al-awar, Toronto, CA;

Methvin Isaac, Brampton, CA;

Anh My Chau, Toronto, CA;

Ahmed Mamai, Mississauga, CA;

Iain Watson, Toronto, CA;

Gennady Poda, Toronto, CA;

Pandiaraju Subramanian, Oakville, CA;

Brian Wilson, Mississauga, CA;

David Uehling, Toronto, CA;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); A61K 31/519 (2006.01); C07D 487/14 (2006.01); A61P 35/04 (2006.01); C07D 471/14 (2006.01); C07D 498/14 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
C07D 487/14 (2013.01); A61P 35/04 (2018.01); C07D 471/14 (2013.01); C07D 498/14 (2013.01); C07D 519/00 (2013.01);
Abstract

The present application relates to compounds of Formula (I) or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, to compositions comprising these compounds or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, and various uses in the treatment of diseases, disorders or conditions that are treatable by inhibiting interactions with BCL6 BTB, such as cancer.


Find Patent Forward Citations

Loading…